These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4435037)

  • 1. Antihypertensive activity of 1-(2-(1,3-dimethyl-2-butenylidene)-hydrazino)-phthalazine (DJ-1461), a new phthalazine derivative.
    Akashi A; Chiba T; Kasahara A
    Eur J Pharmacol; 1974 Nov; 29(1):161-4. PubMed ID: 4435037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Binazine--a new phthalazine derivative].
    Gamski M
    Z Gesamte Inn Med; 1973 Aug; 28(15):Suppl:234-5. PubMed ID: 4765564
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S; Chiba T; Suzuki I; Akashi A
    Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 6-trifluoromethyl-1, 4-dihydrazinophthalazine.
    Cavalleri B; Bellasio E; Sardi A
    J Med Chem; 1970 Jan; 13(1):148-9. PubMed ID: 5412095
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).
    Dorigotti L; Rolandi R; Carpi C
    Pharmacol Res Commun; 1976 Jun; 8(3):295-308. PubMed ID: 17122
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicological studies of 1-[2-(1,3-dimethyl-2-butenylidene)-hydrazino]-phthalazine, a new antihypertensive drug, in mice and rats.
    Onodera T; Takayama S; Yamada A; Ono Y; Akimoto T
    Toxicol Appl Pharmacol; 1978 Jun; 44(3):431-9. PubMed ID: 684739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phthalazine derivatives in the treatment of arterial hypertension].
    Cybulska I
    Kardiol Pol; 1981; 24(10):709-15. PubMed ID: 7329009
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
    Roba J; Lambelin G; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):182-90. PubMed ID: 4404933
    [No Abstract]   [Full Text] [Related]  

  • 11. Central sympathoinhibitory action of a direct-acting vasodilator, budralazine, in anesthetized rats.
    Yoshioka M; Yahagi H; Minami M; Saito H
    Jpn J Pharmacol; 1987 Jun; 44(2):187-96. PubMed ID: 3656776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
    Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
    Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive effects of ecarazine hydrochloride in essential hypertension and its action on the renin-aldosterone system].
    Hata S; Yoshioka M; Kunida H
    Horumon To Rinsho; 1976 Sep; 24(9):919-34. PubMed ID: 795573
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological basis of the symptomatic treatment of arterial hypertension. II. Antihypertensive agent combinations].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Nov; 2(39):2595-600. PubMed ID: 4152250
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the vasodilator action of antihypertensive drug budralazine.
    Chiba T; Hirohashi M; Suzuki I; Tanaka S; Watanabe K; Akashi A
    Arzneimittelforschung; 1983; 33(1):112-6. PubMed ID: 6299307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension: a controllable disease.
    Freis ED
    Clin Pharmacol Ther; 1972; 13(5):627-32. PubMed ID: 5053807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.